ESC 365 - Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

HFA Premium Access

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Session: Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Topic: Comorbidities

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

70 presentations

1 follower

4 more presentations in this session

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Access

Slides

Video

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

Speaker: Professor I. Pina (Philadelphia, US)

Access

Slides

Video

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Speaker: Professor P. Rossignol (Vandoeuvre-Les-Nancy, FR)

Access

Slides

Video

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor J. Butler (Jackson, US)

Access

Slides

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Speakers: Professor F. Zannad, Professor M. Lainscak, Professor I. Pina, Professor P. Rossignol, Professor J. Butler

Access

About the event

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

Congress

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

About the speaker

Professor Faiez Zannad

4 more presentations in this session

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

About the event

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

ESC 365 is supported by